Email this article 
Review Articles
Review of once-monthly oral ibandronate and the use thereof
South African Family Practice | Vol 59, No 4 : July/August| a4728 |
DOI: https://doi.org/10.4102/safp.v59i4.4728
| ©
Submitted: 07 August 2017 | Published:
Submitted: 07 August 2017 | Published:
About the author(s)
T De Villiers,, South AfricaM Davey,, South Africa
B Cassim,, South Africa
W De Lange,, South Africa
Full Text:
PDF (85KB)Abstract
An advisory board meeting of key opinion leaders was held in 2015 to discuss the clinical data on oral ibandronate in the treatment of postmenopausal osteoporosis.
Boniva 150 mg (ibandronate) oral once-monthly is indicated for the treatment of osteoporosis in postmenopausal women, in order to reduce the risk of vertebral fractures.1
Boniva 150 mg (ibandronate) oral once-monthly is indicated for the treatment of osteoporosis in postmenopausal women, in order to reduce the risk of vertebral fractures.1
Keywords
oral ibandronate
Metrics
Total abstract views: 1695Total article views: 676